Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms

Japanese Journal of Cancer Research

Volumn 87, Issue 12, 1996, Pages 1251-1258

  Takeuchi, Eiji ^a   Yanagawa, Hiroaki ^a   Yano, Seiji ^a   Haku, Takashi ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Interleukin 15; Lymphokine activated killer cell; Mononuclear cell; Tumor cytotoxicity

Indexed keywords

CHROMIUM 51; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; CANCER CELL CULTURE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; HUMAN; HUMAN CELL; KILLER CELL; LUNG CANCER; LUNG SMALL CELL CANCER; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 0030453771     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03140.x     Document Type: Article

References (40)

1. Ries, L. G., Pollack, E. S. and Young, J. L. Cancer patient survival: surveillance, epidermiology and end results program, 1973-79. J. Natl. Cancer Inst., 70, 693-707 (1983).
2. Paesmans, M., Sculier, J. P., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Cutsem, O. V., Sergysels, R., Mommen, P. and Klastersky, J. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J. Clin. Oncol., 13, 1221-1230 (1995).
3. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., Seipp, C. A., Simpson, C. G. and White, D. E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med., 316, 889-897 (1987).
4. Yang, S. C., Owen-Schaub, L., Grimm, E. A. and Roth, J. A. Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets. Cancer Immunol. Immunother., 29, 193-198 (1989).
5. Valone, F. H., Gandara, D. R., Deisseroth, A. B., Perez, E. A., Rayner, A., Aronson, F. R., Luce, J. and Paradise, C. Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas. J. Immunother., 10, 207-213 (1991).
6. Lissoni, P., Meregalli, S., Fossati, V., Paolorossi, F., Barni, S., Tancini, G. and Frigerio, F. A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer. Tumori, 80, 464-467 (1994).
7. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D., Anderson, D. M. and Giri, J. G. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science, 264, 965-967 (1994).
8. Bruton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A. A lymphokine, provisionally designated interleukin T and produced by a human adult T cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA, 91, 4935-1939 (1994).
9. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A. The interleukin (IL) 2 receptor β-chain is shared by IL-2 and a cytokine provisionally designated IL-T, that stimulates T cell proliferation and the induction of lymphokine activated killer cells. Proc, Natl. Acad. Sci. USA, 91, 4940-4944 (1994).
10. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K. and Caligiuri, M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med., 180, 1395-1403 (1994).
11. Armitage, R. J., Macduff, B. M., Eisenman, J., Paxton, R. and Grabstein, K. H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol., 154, 483-490 (1995).
12. Wilkinson, P. C. and Liew, F. Y. Chemoattraction of human blood T lymphocytes by IL-15. J. Exp. Med., 181, 1255-1259 (1995).
13. Gamero, A. M., Ussery, D., Reintgen, D. S., Puleo, C. A. and Djeu, J. Y. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res., 55, 4988-4994 (1995).
14. Yonei, T., Ohnoshi, T., Hiraki, S., Ueoka, H., Kiura, K., Moritaka, T., Shibayama, T., Tabata, M., Segawa, Y. and Takigawa, N. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens. Acta Med. Okayama, 47, 233-241 (1993).
15. Sone, S., Inamura, N., Nii, A. and Ogura, T. Heterogeneity of human lymphokine(IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes. Int. J. Cancer, 42, 428-134 (1988).
16. Kato, K., Yamada, T., Kawahara, K., Onda, H., Asano, T., Sugino, H. and Kakinuma, A. Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli. Biochem. Biophys. Res. Commun., 130, 692-699 (1985).
17. Haku, T., Sone, S., Nabioullin, R. and Ogura, T. Human alveolar macrophages augment natural killer cell stimulatory factor (interleukin-12)-inducible killer activity from autologous blood lymphocytes. Jpn. J. Cancer Res., 86, 81-87 (1995).
18. + T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12). Jpn. J. Cancer Res., 85, 853-861 (1994).
19. Sone, S., Utsugi, T., Nii, A. and Ogura, T. Differential effects of recombinant interferons α, β, and γ on induction of human lymphokine (IL-2)-activated killer activity. J. Natl. Cancer Inst., 80, 425-431 (1988).
20. Han, X., Itoh, K., Balch, C. M. and Pellis, N. R. Recombinant interleukin 4 (rIL-4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes. Lymphokine Res., 7, 227-235 (1988).
21. Kawakami, Y., Custer, M., Rosenberg, S. A. and Lotze, M. T. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol., 142, 3452-3461 (1989).
22. Sone, S., Utsugi, T., Nii, A. and Ogura, T. Effects of human alveolar macrophages on the induction of lymphokine (IL 2) activated killer cells. J. Immunol., 139, 29-34 (1987).
23. Nii, A., Sone, S., Utsugi, T., Yanagawa, H. and Ogura, T. Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. Int. J. Cancer, 41, 33-40 (1988).
24. Sone, S., Kunishige, E., Fawzy, F., Yanagawa, H., Nii, A., Maeda, K., Atagi, S., Heike, Y., Nishioka, Y., Mizuno, K. and Ogura, T. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients. Jpn. J. Cancer Res., 82, 716-723 (1991).
25. Giri, J. G., Kumaki, S., Ahdieh, M., Friend, D. J., Loomis, A., Shanebeck, K., Dubose, R., Cosman, D., Park, L. S. and Anderson, D. M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J., 14, 3654-3663 (1995).
26. Yang, S. S., Malek, T. R., Hargrove, M. E. and Ting, C. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic responses. J. Immunol., 134, 3912-3919 (1985).
27. Wakasugi, H., Bertoglio, J., Tursz, T. and Fradelizi, D. IL-2 receptor induction on human T lymphocytes: role for IL-2 and monocytes. J. Immunol., 135, 321-327 (1985).
28. Ochoa, A. C., Gromo, G., Alter, B. J., Sondel, P. M. and Bach, F. H. Long term growth of lymphokine-activated killler (LAK) cells: role of anti-CD-3, β-IL-1, interferon-γ and -β. J. Immunol., 138, 2728-2733 (1987).
29. Owen-Schaub, L. B., Gutterman, J. U. and Grimm, E. A. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor a and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res., 48, 788-792 (1988).
30. Smyth, M. J., Ortaldo, J. R., Bere, W., Yagita, H., Okamura, K. and Young, H. A. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J. Immunol., 145, 1159-1166 (1990).
31. Hsu, D. H., Moore, K. W. and Spits, H. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity. Int. Immunol., 4, 563-569 (1992).
32. Horing, H., Zuber, M., Garotta, G. and Heberer, M. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Cell. Immunol., 146, 391-405 (1993).
33. Martinez, O. M., Gibbons, R. S., Garovoy, M. R. and Aronson, F. R. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J. Immunol., 144, 2211-2215 (1990).
34. Bich-Thuy, L. T., Dukovich, M., Peffer, N. J., Fauci, A. S., Kehrl, J. H. and Greene, W. C. Direct activation of human resting T cells by IL-2: the role of an IL-2 receptor distinct from the Tac protein. J. Immunol., 139, 1550-1556 (1987).
35. Sharon, M., Siegel, J. P., Tosato, G., Yodoi, J., Gerrard, T. L. and Leonard, W. J. The human interleukin 2 receptor β chain (p70): direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J. Exp. Med., 167, 1265-1270 (1988).
36. Siegel, J. P., Sharon, M., Smith, P. L. and Leonard, W. J. The IL-2 receptor β chain (P70): role in mediating signals for LAK, NK, and proliferative activities. Science, 238, 75-78 (1988).
37. Tsudo, M., Goldman, C. K., Bongiovanni, K. F., Chan, W. C., Winton, E. F., Yagita, M., Grimm, E. A. and Waldmann, T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Natl. Acad. Sci. USA, 84, 5394-5398 (1987).
38. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K. and Sugamura, K. Sharing of the interleukin-2 (IL-2) receptor 7 chain between receptors for IL-2 and IL-4. Science, 262, 1874-1877 (1993).
39. Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M. and Sugamura, K. Cloning of the 7 chain of the human IL-2 receptor. Science, 257, 379-382 (1992).
40. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D. and Anderson, D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J., 13, 2822-2830 (1994).